Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

External Validation of the Liverpool Uveal Melanoma Prognosticator Online.

DeParis SW, Taktak A, Eleuteri A, Enanoria W, Heimann H, Coupland SE, Damato B.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6116-6122. doi: 10.1167/iovs.16-19654.

PMID:
27835710
2.

Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.

Lane AM, Kim IK, Gragoudas ES.

JAMA Ophthalmol. 2015 Jul;133(7):792-6. doi: 10.1001/jamaophthalmol.2015.0887.

PMID:
25905597
3.

Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.

Park SJ, Oh CM, Yeon B, Cho H, Park KH.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1909-1915. doi: 10.1167/iovs.16-20077.

PMID:
28362882
4.

International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.

AJCC Ophthalmic Oncology Task Force.

JAMA Ophthalmol. 2015 Apr;133(4):376-83. doi: 10.1001/jamaophthalmol.2014.5395. Erratum in: JAMA Ophthalmol. 2015 Apr;133(4):493. JAMA Ophthalmol. 2015 Sep;133(9):1096.

PMID:
25555246
5.

American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.

Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA.

Ophthalmology. 2015 Jun;122(6):1180-6. doi: 10.1016/j.ophtha.2015.01.026. Epub 2015 Mar 24.

PMID:
25813452
6.
7.
8.

The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.

Bagger M, Andersen MT, Andersen KK, Heegaard S, Andersen MK, Kiilgaard JF.

Invest Ophthalmol Vis Sci. 2014 Dec 23;56(1):438-44. doi: 10.1167/iovs.14-15571.

PMID:
25537201
9.

Artificial neural networks estimating survival probability after treatment of choroidal melanoma.

Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF.

Ophthalmology. 2008 Sep;115(9):1598-607. doi: 10.1016/j.ophtha.2008.01.032. Epub 2008 Mar 14.

PMID:
18342942
10.

Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.

Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):98-103. doi: 10.1016/j.ijrobp.2009.07.1688. Epub 2009 Nov 10.

PMID:
19910136
11.

Very long-term prognosis of patients with malignant uveal melanoma.

Kujala E, Mäkitie T, Kivelä T.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9.

PMID:
14578381
12.

The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.

Al-Jamal RT, Cassoux N, Desjardins L, Damato B, Konstantinidis L, Coupland SE, Heimann H, Petrovic A, Zografos L, Schalenbourg A, Velazquez-Martin JP, Krema H, Bogdali A, Markiewicz A, Romanowska-Dixon B, Metz CH, Biewald E, Bornfeld N, Kiratli H, Bronkhorst IH, Jager MJ, Marinkovic M, Fili M, Seregard S, Frenkel S, Pe'er J, Salvi SM, Rennie IG, Rospond-Kubiak I, Kociecki J, Kiilgaard JF, Heegaard S, Cohen VM, Sagoo MS, Amiryan A, Saakyan S, Eide N, Krohn J, Midena E, Parrozzani R, Grange JD, Kilic E, Blasi MA, Saornil MA, Kivelä TT.

Ophthalmology. 2016 Apr;123(4):898-907. doi: 10.1016/j.ophtha.2015.12.024. Epub 2016 Feb 4.

PMID:
26854035
13.

Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.

Kim IK, Lane AM, Gragoudas ES.

Arch Ophthalmol. 2010 Jul;128(7):871-5. doi: 10.1001/archophthalmol.2010.121.

PMID:
20625048
14.

Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.

Conway RM, Poothullil AM, Daftari IK, Weinberg V, Chung JE, O'Brien JM.

Arch Ophthalmol. 2006 Jun;124(6):838-43.

PMID:
16769837
15.

Salvage proton beam therapy in local recurrent uveal melanoma.

Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM.

Am J Ophthalmol. 2014 Nov;158(5):948-56. doi: 10.1016/j.ajo.2014.07.013. Epub 2014 Jul 16.

PMID:
25038327
16.

Survival after proton-beam irradiation of uveal melanomas.

Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD.

Am J Ophthalmol. 2004 Jun;137(6):1002-10.

PMID:
15183783
17.

Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.

Ophthalmic Oncology Task Force.

Ophthalmology. 2016 Jan;123(1):86-91. doi: 10.1016/j.ophtha.2015.09.014. Epub 2015 Oct 21.

18.

Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.

King B, Morales-Tirado VM, Wynn HG, Gao BT, Ballo MT, Wilson MW.

Am J Ophthalmol. 2017 Apr;176:40-45. doi: 10.1016/j.ajo.2016.12.022. Epub 2016 Dec 31.

PMID:
28048976
19.

Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.

Caujolle JP, Paoli V, Chamorey E, Maschi C, Baillif S, Herault J, Gastaud P, Hannoun-Levi JM.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1218-24. doi: 10.1016/j.ijrobp.2012.10.005. Epub 2012 Nov 22.

PMID:
23177670
20.

Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.

Schmidt-Pokrzywniak A, Kalbitz S, Kuss O, Jöckel KH, Bornfeld N, Stang A.

BMC Ophthalmol. 2014 Apr 1;14:42. doi: 10.1186/1471-2415-14-42.

Supplemental Content

Support Center